InvestorsHub Logo
Followers 0
Posts 135
Boards Moderated 0
Alias Born 11/02/2006

Re: lem114933 post# 14021

Wednesday, 12/06/2006 3:29:15 PM

Wednesday, December 06, 2006 3:29:15 PM

Post# of 29237
Ok, so I'm here.

And I've been doing some more research, but I've got to say, after reading the board for the last couple of days I kinda felt like keeping it to myself.

From being in a very positive frame of mind about things, as soon as the share price rose everyone turned negative. On several points. And again, I know this isn't gonna make me any friends, but.....

1) 504. Obviously these are being used to fund the company as revenues build. There's nothing sinister about a company doing that, or even unusual. Yet there have been calls from people on here that supposedly know lots about trading screaming about how terrible this is. What, that the company is moving form the development phase into revenue generation and is using a common and legal practice to do this? What would be better, to let the company die when it's so close to achieveing all of it's milestones and turning into a profitable entity with a sustainable future? I'm sorry, I fail to see how that's a bad thing.

2) PR. Now, because we don't see a new PR everyday the world is ending. Or so you'd think. A government body has directed it's corporate partner that it should handle it's own marketing. Sacre bleu! Apart from the fact that it is probably against policy for them to issue releases that will make money for corporations, they probably don't have the resource to invest in pumping out press releases all day long. THEY quoted for Medify's release, but the value of this has been killed right here on this board.

3)JB shares. How is this our business? It's his company. We are investing hoping to make money on the back of his (and his teams) work. He grew it to the point where it's delivering a REAL product (and how many pinks don't get that far?) to a REAL market that has publicly stated it wants the product. I am concerned about my own shareholding (which, like the rest of you no-one put a gun to my head and made me buy). And I'd rather not see my investment slated day in day out in a public forum. How anyone can think that slating the company and it's chairman is going to beneficial I'm lost. Obivously the issue will have to resolved if there are any future negotiations, but again, that is work for the board NOT for this discussion group.

4) And on that note, how many companies run themselves based on the opinions expressed anonymously on a forum? Why do we expect Medify to do that? The people involved can only make money if this thing is successful. It has been stated that the new management are putting into place (and delivering already) a strategic sales and marketing plan. And it's working. But because noone is an overnight millionaire proper comercial growth is a bad thing. Please. If you want to get rich overnight gamble on the lottery or Vegas, and then post on one of their bulletins how unfair it is.
And how many of the people that make these comments have actually successfully launched, floated and then sold on a company.

So, I know you probably won't like that rant but it's time to get real. A buyout would be great, but so would a company that is in serious growth, has successfully completed development and is now making sales. Ie, a real, stable company.

I have spoken at length with my contact over the past couple of days and there is definate development. There are ongoing talks, but no-one will comment due to the NDA. The share dividend WILL be issued, the legals in the states are just being completed before the T/A is informed. Nothing sinister.
And sales are coming in. The European activity is also coming back into the mix.

So it's all good.

He doesn't know what is causing the strange activity today, but based on our chat I'm happy to ride it out.

These are just my opinions. If you don't agree, that's fine. Good luck to you.


GH

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.